`
`From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Olinger, Jonathan
`Tuesday, July 25, 2017 3:28 PM
`'Parezo, Jessica'; Mylan-WC-IPR; Stockwell, Mitch; Holloway, Clay
`Reister, Andrea; Kamholz, Scott; MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch,
`LLP (maa@bskb.com); Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP
`(Lynde.Herzbach@bskb.com)
`RE: IPR2017-00203: Dr. McConville's Deposition
`
`Counsel,
`
`Petitioner confirms that it will take Dr. McConville’s deposition on July 17th in Covington’s DC Office.
`
`Petitioner would also like to take the deposition of inventor Masaru Tanjoh in relation to this proceeding. No later than
`July 28, please provide us with Tanjoh-san’s availability for a deposition.
`
`Best regards,
`Jonathan
`
`
`Jonathan D. Olinger
`Kilpatrick Townsend & Stockton LLP
`Suite 2800 | 1100 Peachtree Street NE | Atlanta, GA 30309-4528
`office 404 745 2426 | fax 404 541 3326
`jolinger@kilpatricktownsend.com | My Profile | vCard
`
`From: Parezo, Jessica [mailto:jparezo@cov.com]
`Sent: Friday, July 21, 2017 1:11 PM
`To: Mylan-WC-IPR; Stockwell, Mitch; Holloway, Clay; Olinger, Jonathan
`Cc: Reister, Andrea; Kamholz, Scott; MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch, LLP (maa@bskb.com);
`Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP (Lynde.Herzbach@bskb.com)
`Subject: IPR2017-00203: Dr. McConville's Deposition
`
`Counsel:
`
`
`To facilitate scheduling during Petitioner's discovery period, we offer Dr. McConville's dates of availability for
`deposition at our DC office. The preferred deposition date is the 17th or 18th of August 2017. Alternatively,
`Dr. McConville can be available on August 3rd or 4th.
`
`Please let us know which of those dates would work.
`
`
`Regards,
`Jessica
`
`
`Jessica Parezo
`
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001-4956
`T +1 202 662 5498 | jparezo@cov.com
`
`1
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1021 - Page 1
`
`
`
`www.cov.com
`
`
`
`
`This message is from a law firm and may contain information that is confidential or legally privileged. If you are not the intended recipient, please
`immediately advise the sender by reply e-mail that this message has been inadvertently transmitted to you and delete this e-mail from your system.
`Thank you for your cooperation.
`
`
`
`
`2
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1021 - Page 2
`
`